ENDEXX Corp. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2015
2016
2017
2018
Sales/Revenue
126.30
220.80
418.40
797.50
Cost of Goods Sold (COGS) incl. D&A
305.70
169.20
215.10
451.90
Gross Income
179.40
51.60
203.30
345.70
SG&A Expense
786.80
824.30
510.30
1,213.10
EBIT
966.20
772.70
307.00
867.50
Unusual Expense
-
-
55.00
434.90
Non Operating Income/Expense
67.70
-
-
-
Interest Expense
271.00
4.00
306.70
435.70
Pretax Income
1,169.40
776.70
668.70
1,738.20
Consolidated Net Income
1,169.40
776.70
668.70
1,738.20
Net Income
1,169.40
776.70
668.70
1,738.20
Net Income After Extraordinaries
1,169.40
776.70
668.70
1,738.20
Net Income Available to Common
1,169.40
776.70
668.70
1,738.20
EPS (Basic)
0.01
0.00
0.00
0.01
Basic Shares Outstanding
227,862.50
235,538.60
262,470.80
301,125.60
EPS (Diluted)
0.01
0.00
0.00
0.01
Diluted Shares Outstanding
227,862.50
235,538.60
262,470.80
301,125.60
EBITDA
963.80
770.10
304.30
864.80

About ENDEXX

View Profile
Address
5855 East Surrey Drive
Cave Creek Arizona 85331
United States
Employees -
Website http://www.endexx.com
Updated 07/08/2019
Endexx Corp. is a diversified holding company focused on plant-based nutraceuticals and emerging technologies. The company is comprised of two operating divisions, CBD Unlimited and M3Hub: Autospenseā„¢. CBD Unlimited is focused on the research, formulation and distribution of medicinal grade, certified industrial hemp extracts for the nutraceutical industry.